hotspot -WSS

hotspot

author：entertainment 2025-09-27 19:28:17 - browse：39

Illustration of a teal cancer cell. -- health coverage from STAT — Illustration of a teal cancer cell. Adobe

Sana Biotechnology, a startup that just a couple of years ago raised over $1 billion off a grand plan to create a portfolio of powerful medicines, said Tuesday it would lay off nearly a third of its employees and de-prioritize one of its most ambitious programs as it looks to save money.

The layoffs are Sana’s second round of cuts in less than a year. It laid off 15% of staff last November after axing another program.

Tuesday’s move pushed back a program focused on turning a patient’s own immune cells into cancer-killing assassins or curing blood disorders such as sickle cell with just an IV infusion. Known as in vivo reprogramming, it was originally the company’s central focus and would have amounted to a monumental breakthrough.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

hotspot

WSS

Biotech startup Celsius cuts 75% of staff ahead of first trial start

It costs an awful lot of money to give away a kidney

ASCO eve: Let’s set the table for this year's meeting

Biogen joins immunology wave with $1.15 billion acquisition of HI

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Fentanyl is making it harder to start addiction treatment

leisure time

hotspot

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Investigation reveals sickle cell patients pressured into sterilizations

Guidelines to prevent youth baseball injuries need more muscle

A controversial new treatment promises to make little people taller

Heart attack and stroke risk calculators need revising

A controversial new treatment promises to make little people taller

Anesthesiologist group: stop taking Ozempic before surgery

'Null' research findings aren't empty of meaning. Let's publish them

Guidelines to prevent youth baseball injuries need more muscle

UnitedHealth argues against case alleging wrongful AI care denials

explore

Bird flu surveillance in wastewater gets boost from consortium

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Heart disease in astronauts blamed on cosmic radiation

As a primary care physician, here's how I hope to partner with AI

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

FDA scientists endorse Pfizer/BioNTech Covid

focus

focus

hotspot

leisure time